Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
mTOR (mammalian target of rapamycin) is a serine/threonine kinase that acts as a central regulator integrating signals from nutrients, growth factors, energy status, and stress to control fundamental cellular processes including cell growth, proliferation, protein synthesis, lipid synthesis, organelle biogenesis, and autophagy. It forms two distinct multi-protein complexes, mTORC1 and mTORC2, each with different functions and sensitivities to inhibitors. Dysregulation of the mTOR pathway is implicated in various diseases, including cancer, metabolic disorders, and neurodegenerative diseases, making it an important therapeutic target.
Inhibition of mTORC1 and/or mTORC2 kinase activity.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mammalian target of rapamycin kinase (mTOR).